Document 0371
 DOCN  M9590371
 TI    Implantable venous access device infections in patients with AIDS.
 DT    9509
 AU    Hellard ME; Pickles R; Fuller A; Spelman D; Alfred Hospital, Melbourne.
 SO    Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:119 (unnumbered
       abstract). Unique Identifier : AIDSLINE ASHM6/95291728
 AB    Totally implantable central venous access devices (trade
       name--Infusaport [IFP]) are used increasingly in AIDS patients for home
       and inpatient therapy. This report reviews the number of IFP's implanted
       in patients from the Alfred Hospital Infectious Diseases Unit between
       January 1992 and June 1994, and the incidence and management of
       infections associated with these devices. Thirty-six patients had 47
       IFP's implanted. There were a total of 12 IFP related infections in 9
       patients. Infection was defined as: 1. Local infection--erythema,
       tenderness and induration with or without fever. 2. Tunnel infection. 3.
       Septicaemia. a) positive blood cultures drawn from the IFP, peripheral
       vein or both sites without an identifiable focus for the infection
       elsewhere. b) Presumed catheter sepsis where clinical signs of
       septicaemia are present despite multiple negative blood cultures,
       resolving within 72 hours of the device's removal. A wide variety of
       organisms was isolated, the most common being a coagulase negative
       Staphylococcus. All patients received intravenous antibiotics and 5 had
       antibiotic locks within the IFP. No infection fully resolved until the
       IFP device was removed. An update of this experience will be given.
 DE    AIDS-Related Opportunistic Infections/*ETIOLOGY  *Catheters, Indwelling
       Cross Infection/*ETIOLOGY  Equipment Failure  Human  Risk Factors
       Septicemia/*ETIOLOGY  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).